2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow aplaviroc: new trials by email Literature Review of aplaviroc trials Research Report on aplaviroc
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GW873140 In Combination With Combivir In HIV Infected Subjects GW873140, Combivir - Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 2 | Terminated | ViiV Healthcare | 125 | 2005-01-01 | 2017-05-30 |
| GW873140 In Combination With Kaletra In HIV Infected Subjects GW873140, Kaletra (lopinavir/ritonavir) - Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 2 | Terminated | ViiV Healthcare | 175 | 2004-12-01 | 2017-05-30 |
| GW873140 to Treat HIV-1 Infected Adults GW873140 - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2004-01-01 | 2008-03-04 |
HIV Infections (3) · Infections (2)
ViiV Healthcare (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3) · Canada (2) · France (2) · Germany (2) · Italy (2) · Portugal (2) · Spain (2) · United Kingdom (2) · Belgium (1) · Denmark (1) · Netherlands (1)